PDI/Bayer Detailing Focuses On Cipro, Avelox After Baycol Withdrawal
Executive Summary
PDI and Bayer are discussing which product will replace Bayer's withdrawn cholesterol-lowering agent Baycol in their contract sales agreement
You may also be interested in...
Bayer Vardenafil Launch To Use Men’s Health Reps; Cipro To Be Detailed Initially
Bayer is creating a 100- to 150-rep men's health specialty sales force in anticipation of FDA approval of its erectile dysfunction product vardenafil
Bayer Vardenafil Launch To Use Men’s Health Reps; Cipro To Be Detailed Initially
Bayer is creating a 100- to 150-rep men's health specialty sales force in anticipation of FDA approval of its erectile dysfunction product vardenafil
Bayer Avelox I.V. Price To Depend On Hospital Purchase Share Vs. Quinolones
Bayer's price for Avelox I.V. will depend on the proportion of moxifloxacin ordered by a hospital relative to other quinolones